Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Memantine in moderate-to-severe Alzheimer disease evidence and ethics based?
Rikkert MG, Dekkers WJ, Scheltens P, Verhey F. Rikkert MG, et al. Among authors: scheltens p. Alzheimer Dis Assoc Disord. 2004 Jan-Mar;18(1):47-8; author reply 48. doi: 10.1097/00002093-200401000-00010. Alzheimer Dis Assoc Disord. 2004. PMID: 15195464 No abstract available.
Multiple diagnostic tests are needed to assess multiple causes of dementia.
Olde Rikkert MG, van der Flier WM, de Leeuw FE, Verbeek M, Jansen RW, Verhey F, Scheltens P. Olde Rikkert MG, et al. Among authors: scheltens p. Arch Neurol. 2006 Jan;63(1):144-6. doi: 10.1001/archneur.63.1.144. Arch Neurol. 2006. PMID: 16401751 No abstract available.
Development of quality indicators for memory clinics.
Drasković I, Vernooij-Dassen M, Verhey F, Scheltens P, Rikkert MO. Drasković I, et al. Among authors: scheltens p. Int J Geriatr Psychiatry. 2008 Feb;23(2):119-28. doi: 10.1002/gps.1848. Int J Geriatr Psychiatry. 2008. PMID: 17582827
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Dubois B, et al. Among authors: scheltens p. Lancet Neurol. 2007 Aug;6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3. Lancet Neurol. 2007. PMID: 17616482 Review.
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Visser PJ, Verhey F, Knol DL, Scheltens P, Wahlund LO, Freund-Levi Y, Tsolaki M, Minthon L, Wallin AK, Hampel H, Bürger K, Pirttila T, Soininen H, Rikkert MO, Verbeek MM, Spiru L, Blennow K. Visser PJ, et al. Among authors: scheltens p. Lancet Neurol. 2009 Jul;8(7):619-27. doi: 10.1016/S1474-4422(09)70139-5. Epub 2009 Jun 10. Lancet Neurol. 2009. PMID: 19523877
1,269 results